- Tytuł:
- Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study.
- Autorzy:
- Temat:
-
ALEMTUZUMAB
MULTIPLE sclerosis
DISEASE relapse
CLINICAL trials
INTERFERONS - Źródło:
- Therapeutic Advances in Neurological Disorders; 9/21/2023, p1-16, 16p
Czasopismo naukowe